Recent advancements in the cardiovascular drug carriers

Abstract

Cardiovascular disease is the disease that affects the cardiovascular system, vascular diseases of the brain and kidney, and peripheral arterial disease. Despite of all advances in pharmacological and clinical treatment, heart failure is a leading cause of morbidness and mortality worldwide. Many new therapeutic advance strategies, including cell transplantation, gene delivery or therapy, and cytokines or other small molecules, have been research to treat heart failure. The main aim of this review article is to focus on nano carriers advancement and addressing the problems associated with old and modern therapeutics such as nonspecific effects and poor stability.

Keywords::

• cardiovascular disease
• gene therapy
• nanotechnological approaches
• Nanoparticle

Declaration of interest

The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper.

Dr. Amit K. Goyal is thankful to the Indian Council of Medical Research (ICMR) (New Delhi, India) for providing financial assistance to carry out this research.